12,524 Shares in CVS Health Co. (NYSE:CVS) Purchased by Mill Creek Capital Advisors LLC

Mill Creek Capital Advisors LLC purchased a new position in CVS Health Co. (NYSE:CVS) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 12,524 shares of the pharmacy operator’s stock, valued at approximately $740,000.

A number of other institutional investors also recently bought and sold shares of CVS. Gryphon Financial Partners LLC raised its stake in shares of CVS Health by 48.3% during the 4th quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock valued at $654,000 after buying an additional 2,653 shares during the last quarter. Congress Wealth Management LLC DE boosted its position in CVS Health by 126.0% in the 4th quarter. Congress Wealth Management LLC DE now owns 6,827 shares of the pharmacy operator’s stock worth $539,000 after purchasing an additional 3,806 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of CVS Health by 18.2% during the 4th quarter. Parallel Advisors LLC now owns 24,257 shares of the pharmacy operator’s stock worth $1,915,000 after purchasing an additional 3,732 shares during the period. Mitchell Sinkler & Starr PA increased its holdings in shares of CVS Health by 7.0% during the 4th quarter. Mitchell Sinkler & Starr PA now owns 6,229 shares of the pharmacy operator’s stock valued at $492,000 after purchasing an additional 410 shares in the last quarter. Finally, United Services Automobile Association lifted its stake in shares of CVS Health by 5.5% in the 4th quarter. United Services Automobile Association now owns 38,141 shares of the pharmacy operator’s stock valued at $3,012,000 after purchasing an additional 1,994 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CVS has been the topic of several analyst reports. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research report on Monday, September 16th. Deutsche Bank Aktiengesellschaft cut their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Evercore ISI lowered their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 price objective on shares of CVS Health in a report on Wednesday, September 4th. Finally, Wells Fargo & Company upped their target price on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Eleven investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Stock Performance

NYSE CVS opened at $57.57 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The stock’s fifty day moving average is $58.28 and its two-hundred day moving average is $62.32. The firm has a market capitalization of $72.27 billion, a P/E ratio of 10.12, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter in the previous year, the company posted $2.21 EPS. The company’s revenue was up 2.6% compared to the same quarter last year. On average, research analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.62%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.